Pages tagged: FDA

7th Annual Stem Cell Policy Event at The Baker Institute at Rice

News

On Friday, September 29, The Texas Heart Institute’s Dr. Joseph G. Rogers, Duke Clinical Research Institute’s Dr. Adrian Hernandez, and...

Burgeoning Hybrid Atrial Fibrillation Program at THI Bolstered by FDA Approval of Innovative New EPi-Sense Treatment System

News

Dr. Jennifer Cozart Now Seeks to Further Expand THI’s Cutting-Edge Atrial Fibrillation Minimally Invasive Hybrid Treatment for Patients Suffering from...

Is Transcatheter Aortic Valve Replacement (TAVR) an FDA approved operation?

FAQ

Yes, this procedure has been FDA-approved for the last two years. The major risk apart from death (from any procedure)...